Abdelwahab Omri

Prof. Abdelwahab Omri

Chemistry/Biochemistry, Laurentian University, Sudbury, Ontario, Canada
orcid

Research Focus & Metrics

Academic Career Length

38Years (1989-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 January 2021 in Molecules
Verified
Journal Article
Open access
PDF file
JJJhanvi Jhaveri
Jhanvi Jhaveri
ZRZarna Raichura
Zarna Raichura
Tabassum KhanTabassum Khan
Tabassum Khan
MMMunira Momin
Munira Momin
Abdelwahab OmriAbdelwahab Omri
Abdelwahab Omri
Nanotechnology-based development of drug delivery systems is an attractive area of research in formulation driven R&D laboratories that makes administration of new and complex drugs feasible. It plays a significant role in the design of novel dosage forms by attributing target specific drug delivery, controlled drug release, improved, patient friendly drug regimen and lower side effects. Polysaccharides, especially chitosan, occupy an important place and are widely used in nano drug delivery systems owing to their biocompatibility and biodegradability. This review focuses on chitosan nanoparticles and envisages to provide an insight into the chemistry, properties, drug release mechanisms, preparation techniques and the vast evolving landscape of diverse applications across disease categories leading to development of better therapeutics and superior clinical outcomes. It summarizes recent advancement in the development and utility of functionalized chitosan in anticancer therapeutics, cancer immunotherapy, theranostics and multistage delivery systems.

24 July 2006 in Journal of the Science of Food and Agriculture
Verified
Journal Article
Closed access
PDF file
M. R. MozafariM. R. Mozafari
M. R. Mozafari
JFJohn Flanagan
John Flanagan
LMLara Matia‐Merino
Lara Matia‐Merino
AAAjay Awati
Ajay Awati
Abdelwahab OmriAbdelwahab Omri
Abdelwahab Omri
HSHarjinder Singh
Harjinder Singh

1 January 2004 in Drug Delivery
Verified
Journal Article
Closed access
MAMichael Anderson
Michael Anderson
Abdelwahab OmriAbdelwahab Omri
Abdelwahab Omri
Liposomes are colloidal carriers that form when certain (phospho)lipid molecules are hydrated in an aqueous media with some energy input. The ideal liposome formulation with optimum stability will improve drug delivery by decreasing the required dose and increasing the efficacy of the entrapped drug at the target organ or tissue. The most important parameter of interest in this article was to compare the efficacy of three different liposomes formulated with DSPC, DMPC, and DPPC, all saturated neutral phospholipids with different acyl chain lengths and transition temperatures. DMPC has a phase transition temperature (Tc) below 37 degrees C, whereas the other two phospholipids possess Tcs above the physiological temperature. These lipids were then added to a cholesterol concentration of 21% to optimize the stability of the vesicles. The liposomes were prepared by a sonication and incubated in phosphate buffered saline (PBS) at 4 degrees C and 37 degrees C. The encapsulation efficiency, initial size, and drug retention of the vesicles were tested over a 48-hr period employing radiolabeled inulin as a model drug. The phase transition temperature of liposomes, which depends on the Tc of the constituent lipids, was an important factor in liposome stability. Of all the liposomes tested, the greatest encapsulation efficiency was found for the DSPC liposomes (2.95%) that also had the greatest drug retention over 48 hr at both 4 degrees C (87.1 +/- 6.8%) and 37 degrees C (85.2 +/- 10.1%), none of these values being significantly different from time zero. The lowest drug retention was found for DMPC liposomes for which a significant difference in drug retention was seen after only 15 min at both 4 degrees C (47.3 +/- 6.9%) and 37 degrees C (53.8 +/- 4.3%). The DPPC liposomes showed a significant difference in drug retention after 3 hr at 4 degrees C (62.1 +/- 8.2%) and after 24 hr at 37 degrees C (60.8 +/- 8.9%). Following the initial drop at certain time intervals a plateau was reached for all of the liposome formulations after which no significant difference in drug retention was observed. In conclusion, liposomes with higher transition temperatures appear to be more stable in PBS either at 4 degrees C or 37 degrees C, indicating that the increase in acyl chain length (and therefore transition temperature) is directly proportional to stability.

26 December 2013 in ISRN Pharmaceutics
Verified
Journal Article
Open access
PDF file
SGShweta Gupta
Shweta Gupta
RKRajesh Kesarla
Rajesh Kesarla
Abdelwahab OmriAbdelwahab Omri
Abdelwahab Omri
Poorly water-soluble drug candidates are becoming more prevalent. It has been estimated that approximately 60–70% of the drug molecules are insufficiently soluble in aqueous media and/or have very low permeability to allow for their adequate and reproducible absorption from the gastrointestinal tract (GIT) following oral administration. Formulation scientists have to adopt various strategies to enhance their absorption. Lipidic formulations are found to be a promising approach to combat the challenges. In this review article, potential advantages and drawbacks of various conventional techniques and the newer approaches specifically the self-emulsifying systems are discussed. Various components of the self-emulsifying systems and their selection criteria are critically reviewed. The attempts of various scientists to transform the liquid self-emulsifying drug delivery systems (SEDDS) to solid-SEDDS by adsorption, spray drying, lyophilization, melt granulation, extrusion, and so forth to formulate various dosage forms like self emulsifying capsules, tablets, controlled release pellets, beads, microspheres, nanoparticles, suppositories, implants, and so forth have also been included. Formulation of SEDDS is a potential strategy to deliver new drug molecules with enhanced bioavailability mostly exhibiting poor aqueous solubility. The self-emulsifying system offers various advantages over other drug delivery systems having potential to solve various problems associated with drugs of all the classes of biopharmaceutical classification system (BCS).

29 May 2022 in Antibiotics
Verified
Journal Article
Open access
PDF file
VSVasanti Suvarna
Vasanti Suvarna
ANArya Nair
Arya Nair
RMRashmi Mallya
Rashmi Mallya
Tabassum KhanTabassum Khan
Tabassum Khan
Abdelwahab OmriAbdelwahab Omri
Abdelwahab Omri
Food packaging plays a key role in offering safe and quality food products to consumers by providing protection and extending shelf life. Food packaging is a multifaceted field based on food science and engineering, microbiology, and chemistry, all of which have contributed significantly to maintaining physicochemical attributes such as color, flavor, moisture content, and texture of foods and their raw materials, in addition to ensuring freedom from oxidation and microbial deterioration. Antimicrobial food packaging systems, in addition to their function as conventional food packaging, are designed to arrest microbial growth on food surfaces, thereby enhancing food stability and quality. Nanomaterials with unique physiochemical and antibacterial properties are widely explored in food packaging as preservatives and antimicrobials, to extend the shelf life of packed food products. Various nanomaterials that are used in food packaging include nanocomposites composing nanoparticles such as silver, copper, gold, titanium dioxide, magnesium oxide, zinc oxide, mesoporous silica and graphene-based inorganic nanoparticles; gelatin; alginate; cellulose; chitosan-based polymeric nanoparticles; lipid nanoparticles; nanoemulsion; nanoliposomes; nanosponges; and nanofibers. Antimicrobial nanomaterial-based packaging systems are fabricated to exhibit greater efficiency against microbial contaminants. Recently, smart food packaging systems indicating the presence of spoilage and pathogenic microorganisms have been investigated by various research groups. The present review summarizes recent updates on various nanomaterials used in the field of food packaging technology, with potential applications as antimicrobial, antioxidant equipped with technology conferring smart functions and mechanisms in food packaging.

14 April 2021 in Expert Opinion on Drug Delivery
Verified
Journal Article
Closed access
NDNeha Desai
Neha Desai
MMMunira Momin
Munira Momin
Tabassum KhanTabassum Khan
Tabassum Khan
SGSankalp Gharat
Sankalp Gharat
RNRaghumani Singh Ningthoujam
Raghumani Singh Ningthoujam
Abdelwahab OmriAbdelwahab Omri
Abdelwahab Omri
Introduction: The targeted delivery of anti-cancer agents to the tumour is a major challenge because most of the drugs show off-target effect resulting in nonspecific cell death. Multi-functionalized metallic nanoparticles (NPs) are explored as a new carrier system in the era of cancer therapeutics. Researchers have investigated the potential of metallic NPs to target tumour cells by active and passive mechanisms, thereby reducing the off-target effects of the anticancer agents. Moreover, photocatalytic activity of upconversion nanoparticles (UCNPs) and the enhanced permeation and retention (EPR) effect have also gained a wide potential in the treatment of cancer. Recent advancement in the field of nanotechnology highlights their potency for cancer therapy. Areas covered: This review summarizes the types of gold and silver metallic NPs with the targeting mechanisms and their potentiality in cancer therapy. Expert opinion: Recent advances in the field of nanotechnology for cancer therapy offers high specificity and targeting efficiency. Targeting the tumour cells through mechanistic pathways using metallic NPs for the disruption/alteration of the molecular profile and survival rate of the tumour cells has led to an effective approach for cancer therapeutics. This alteration in the survival rate of the tumour cells might decrease the proliferation thereby resulting in more efficient management in the treatment of cancer.